Key facts
- Notable investors include 500 Global.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Chi Longevity
- ·The full record, as it builds
Funding rounds
No funding rounds for Chi Longevity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chi Longevity
Operator of a longevity-focused medical clinic intended to slow biological aging and enhance overall healthspan. The company offers a wide range of services such as discreet care, detailed assessment, comprehensive interventions, biological phenotyping, clinical phenotyping, and re-assessment, enabling health-conscious individuals to have access to personalized and preventative care and reduce age-related risks through a science-driven path.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2022
- Employees
- 19
- Website
- chilongevity.com/
- Ownership
- Privately Held (backing)
Chi Longevity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chi Longevity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chi Longevity in its N-PORT filings yet. We sweep new filings monthly.